SEC Form 4/A · accession 0001380389-17-000035
Oncolix, Inc. · ONCX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Brian K Kistler
Other
Period of report
Mar 7, 2017
Accepted (ET)
Apr 14, 2017 · 10:28 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001584137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Mar 7, 2017 | M | 60,000,000 | $0.0019 | A | 61,465,730 | D | |
| Common StockF5 | Apr 4, 2017 | S | 61,465,730 | $0.0051 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of common stock were acquired by the reporting person as the result of the conversion of a $119,331.00 debt owed by the issuer dated June 25, 2013.
- F2The shares of common stock were acquired by the reporting person as the result of the conversion of a $119,331.00 debt owed by the issuer dated June 25, 2013.
- F3The shares of common stock were acquired by the reporting person as the result of the conversion of a $119,331.00 debt owed by the issuer dated June 25, 2013.
- F4The shares of common stock were sold by the reporting person in a private transaction to Oncolix, Inc., a Delaware corporation, in connection with a change of control of the issuer.
- F5The shares of common stock were sold by the reporting person in a private transaction to Oncolix, Inc., a Delaware corporation, in connection with a change of control of the issuer.